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A continuous luminescence assay for monitoring kinase activity: signalling the ADP/ATP ratio using a discrete europium complex † Sarah H. Hewitt, Jonathan Parris, Romain Mailhot and Stephen J. Butler *
We report the application of a stable cationic europium complex [Eu. 1] + in a continuous-read luminescence assay for kinase activity.
[Eu.1] + binds reversibly to ATP and ADP in water, at neutral pH, in the presence of Mg 2+ ions, providing distinctive luminescence responses that permits the kinase-catalysed conversion of ATP to ADP to be monitored in real-time.
Monitoring enzymatic activity in real-time is of fundamental importance to biological and biomedical researchers. It enables enzyme kinetics and thus enzyme mechanism to be determined, a crucial first step in the discovery of new inhibitors and activators of enzymes. 1 Nucleoside polyphosphate (NPP) anions such as ATP, ADP, GTP and GDP are important substrates for a number of pharmaceutically relevant enzymes, most prominently in drug discovery programmes involving kinases and GTPases. 2, 3 Kinases catalyse the phosphorylation of proteins, converting ATP to ADP in the process. Dysregulation of kinase activity, resulting in changes in selectivity and frequency of substrate phosphorylation, is the primary cause of a number of cancers. Therefore, kinases represent one of the most promising targets in oncological drug discovery. 4 The search for new kinase inhibitors currently begins with highthroughput screening of potential leads followed by measurements of selectivity and potency. However, the majority of commercial kinase activity assays are restricted to single end-point measurements (e.g. ADPGlo, 5 HTRF KinEASE, 6 DELFIA 7 ), which give no kinetic and thus no mechanistic information. Current assays typically require the use of either expensive antibodies to detect the phosphorylated peptide substrate, or fluorescent/radiolabelled substrates, which precludes the use of natural peptides or proteins. Crucially, there is no low-cost method available for continuous reporting of kinase activity, which significantly limits our understanding of kinase kinetics and inhibition mechanisms.
In this work we have developed an alternative approach to monitor kinase activity, which involves the use of a stable luminescent europium(III) complex, [Eu. 1] + , that binds reversibly to ATP and ADP, providing distinctive emission spectral responses, enabling the change in ADP/ATP ratio to be dynamically followed during a kinase reaction (Fig. 1a) . Measuring the ADP/ATP ratio instead of the production of specific phosphorylated substrates, could permit a range of kinases to be screened readily. Crucially, our assay does not require the use of expensive antibodies to recognise a specific phosphorylated substrate. We recently reported a fluorescent tripodal zinc(II) complex, Zn.L 1 , capable of the selective recognition of ATP at physiological pH (Fig. 1a) . 13 . A high level of sensing selectivity between GTP and GDP was also achieved (Fig. S14, ESI †) . Apparent association constants were determined for ATP and ADP to be log K a = 3.7 and 4.1 respectively, slightly lower than those determined in the absence of Mg 2+ ions (Table 1) . Affinity constants for monophosphate species could not be determined under these conditions as only minor changes in Eu(III) emission took place. The striking differences between the emission spectral responses to ATP and ADP in a background of MgCl 2 allowed us to monitor the kinase-catalysed conversion of ATP to ADP in real-time. Initially, we simulated a kinase reaction by increasing the molar ratio of ADP/ ATP systematically, whilst keeping the total concentration of ATP and ADP constant (1 mM). The stepwise increase in emission intensity of [Eu. 1] + with decreasing ATP concentration and increasing ADP concentration is shown in Fig. 3a . The large increase in intensity at 616.5 nm within the hypersensitive DJ = 2 manifold precisely indicates the ratio of ADP/ATP, while emission intensity at 599.5 nm within the DJ = 1 manifold remains constant, indicating total nucleoside (and [Eu.1] + ) present. This is exactly the type of ratiometric signalling that we hoped to achieve in our enzyme assay, as it increases precision, improves signal-to-noise and minimises artefacts arising from variations in concentration of [Eu.1] + or liquid handling. A plot of the change in the intensity ratio at 616.5/ 599.5 nm versus mole fraction of ADP is approximately linear (Fig. 3b ). Significant modulation of Eu(III) emission is evident at 20% conversion of ATP to ADP, indicating that [Eu.1] + may be used to determine initial enzyme reaction rates and thus, the effect of kinase inhibitors. Simulation of a GTPase reaction was also possible, whereby the change in ratio of GDP/GTP is signalled by a ratiometric change in luminescence (Fig. S14, ESI interfere with the measurement of the ADP/ATP ratio ( Fig. S15-S18 , ESI †). The enzyme assay was then performed in following order: PKAc was added last to a solution containing all the other assay components and measurements were taken every 96 seconds. § As the phosphorylation of the substrate takes place, the ratio of ADP/ATP increases. As a result, the intensity of the DJ = 2 band centred at 616.5 nm increases, whereas the emission intensity at 599.5 nm within the DJ = 1 manifold remains constant (Fig. S19 , ESI †), consistent with the ratiometric calibration plot in Fig. 3b . Time-trace plots of the kinase reaction using different concentrations of PKAc (0.05-0.4 mM) are shown in Fig. 4 . The plots clearly reveal that using higher concentrations of PKAc results in the overall emission intensity of [Eu. 1] + increasing at a faster rate. Comparable time traces were obtained by following the emission intensity ratio at 616.5/599.5 nm (Fig. S20, ESI †) . Importantly, the background reaction in the absence of the enzyme shows essentially no change in emission intensity over time. For the first 10 minutes of each reaction, the increase in emission intensity at 616.5/599.5 nm can be fitted linearly to a monoexponential function (Fig. 4b) . The slope of the fit indicates the initial rate of reaction, which depends linearly on the concentration of enzyme used.
To demonstrate the utility of [Eu.1] + in inhibition experiments, the broad spectrum kinase inhibitor staurosporine was added to the reaction mixture containing 0.4 mM PKAc. ¶ The time-trace plots in Fig. 5 and Fig. S22 , S23 (ESI †) reveal that PKAc activity is inhibited significantly in the presence of 0.2 mM staurosporine, whereas 0.4 mM of the inhibitor almost completely deactivates the enzyme and very little phosphorylation occurs. This data is consistent with the strong inhibitory effect of staurosporine on PKAc activity (IC 50 = 15 nM) 22 
